Drug resistance in targeted cancer therapies with RAF inhibitors
Cancer stem cells, epithelial-mesenchymal transition, ATP and their roles in drug resistance in cancer
Clinical significance of the loss of CD20 antigen on tumor cells in patients with relapsed or refractory follicular lymphoma
Protective autophagy by thymidine causes resistance to rapamycin in colorectal cancer cells <i>in vitro</i>
Favorable clinical outcomes of checkpoint inhibitor-based combinations after progression with immunotherapy in advanced non-small cell lung cancer
Cost-effectiveness of Osimertinib in activating epidermal growth factor receptor gene (<i>EGFR</i>)-mutations in first-line for advanced non-small cell lung cancer